New incident report
Incident Report Number: 2019-5069
Registrant Reference Number: USA-BAYERBAH-2019-US0045835 (Report 588564)
Registrant Name (Full Legal Name no abbreviations): Bayer inc
Address: 2920 Matheson Blvd
City: Mississaugua
Prov / State: ON
Country: Canada
Postal Code: L4W 5R6
Domestic Animal
Country: UNITED STATES
Prov / State: TEXAS
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. Unknown
Product Name: advantageII pipette size unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. Unknown
Product Name: Advantage Spot-on pipette size unknown
Other (specify)
spot onYes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Cat / Chat
unknown
1
Unknown
Unknown
Unknown
Skin
Unknown / Inconnu
Unknown / Inconnu
System
Unknown / Inconnu
Unknown
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unspecified date in 2015, post application, the cat developed a thyroid disorder NOS. It was unknown if the cat was examined or treated by a veterinarian. On an unspecified date post application and post onset of the clinical sign, in 2015, the cat died. It is not known if a necropsy was performed. Due to the sensitive nature of the communication, specific relevant details were not obtained, nor will such be sought. The intent of the call was to inquire about product use in general and not to report this event. No further information is expected. This case is closed.
Death
Advantage Plus Spot-on pipette size unknown O - Unclassifiable/unassessable Reported thyroid disorder and death are not expected with topical product application. They are not consistent with pharmaco-toxicological product profile. Product has wide margin of safety. Oral LD50 in rat is 642 mg/kg BW. 24-fold overdosage tolerated by cats without showing any side effect. Additionally, the intent of the call was to inquire about product use in general and not to report this event. However time to onset is unknown. Other causes must be considered. Overall, product relation for the case is unassessable. Advantage Spot-on pipette size unknown N - Unlikely Reported thyroid disorder and death are not expected with topical product application. They are not consistent with pharmaco-toxicological product profile. Product has wide margin of safety. Oral LD50 in rat is 642 mg/kg BW. 24-fold overdosage tolerated by cats without showing any side effect. Additionally, the intent of the call was to inquire about product use in general and not to report this event. Time to onset is too long (5 years). Overall, a product relation for the case is considered unlikely.